Skip to main content

ZACKS INVESTMENT MANAGEMENT

Position in GILD — Gilead Sciences, Inc.

CIK 1086483 Chicago, IL

Position in GILD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$67,070,115
-$7,603,215 QoQ
Shares Held
530,870
-0.9% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#179
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ZACKS INVESTMENT MANAGEMENT holds $890,953,075 across 8 Drug Manufacturers - General names. GILD ranks #5 (7.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 GILD
Gilead Sciences, Inc.
This page
530,870 $67,070,115

All Filings in GILD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $67,070,115 530,870
2026-03-31 $74,673,330 535,792
2025-12-31 $67,268,516 548,057
2025-09-30 $50,347,935 453,585
2025-06-30 $49,666,323 447,969
2025-03-31 $49,836,814 444,773
2024-12-31 $30,941,456 334,973
2024-09-30 $30,966,974 369,358
2024-06-30 $23,070,729 336,259
2024-03-31 $24,086,138 328,821
2023-12-31 $58,131,884 717,589
2023-09-30 $56,339,892 751,800
2023-06-30 $57,764,504 749,507
2023-03-31 $61,694,334 743,574
2022-12-31 $61,989,795 722,071
2022-09-30 $36,159,223 586,144
2022-06-30 $35,166,305 568,942
2022-03-31 $31,952,710 537,472
2021-12-31 $36,798,312 506,794
2021-09-30 $34,861,506 499,091
2021-06-30 $33,460,657 485,923
2021-03-31 $29,887,691 462,443
2020-12-31 $28,045,257 481,381
2020-09-30 $37,179,226 588,372
2020-06-30 $39,450,215 512,740
2020-03-31 $40,276,127 538,739